Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-4995|128|3|593-596

ISSN： 0023-852x

Source： THE LARYNGOSCOPE, Vol.128, Iss.3, 2018-03, pp. : 593-596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case Report of a Patient with Hereditary Hemorrhagic Telangiectasia Treated Successively with Thalidomide and Bevacizumab

By  

Case Reports in Oncology, Vol. 3, Iss. 3, 2010-12 ,pp. : 463-470

Karger

Access to resources Recommend Favorite

Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double‐blind, randomized, placebo‐controlled trial

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 6, 2015-06 ,pp. : 783-787

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature

By  

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, Vol. 5, Iss. 11, 2015-11 ,pp. : 1042-1047

John Wiley & Sons Inc

Access to resources Recommend Favorite

HEREDITARY HEMORRHAGIC TELANGIECTASIA WITH MALIGNANT LYMPHOMA An Autopsy Case

By  

PATHOLOGY INTERNATIONAL, Vol. 38, Iss. 3, 1988-03 ,pp. : 383-391

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Lung in Hereditary Hemorrhagic Telangiectasia

By  

Respiration, Vol. 94, Iss. 4, 2017-08 ,pp. : 315-330

Karger

Access to resources Recommend Favorite